
ASH 2022: Short-course Brentuximab Vedotin with Chemotherapy is Highly Active in Early-Stage Bulky Hodgkin LymphomaASH…

Where Are They Now? Deborah Stephens, DO When did you become interested in the study…

A Multi-Layered View to Lymphoma Research Some people are born to be scientists, and Eric…

On January 27, 2023 the U.S. Food and Drug Administration (FDA) announced it has approved pirtobrutinib…

On January 19, the U.S. Food and Drug Administration (FDA) announced it has approved bruton tyrosine…

On December 22, 2022, the U.S. Food and Drug Administration (FDA) announced it has approved…

December 23, 2022 – It is with great sadness that the Lymphoma Research Foundation (LRF)…

No parent should ever have to go through the excruciating experience of losing a child.…

Roy Bridges has the type of life story you need to read to believe. Starting…